These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 17667604
1. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate. Boruban C, Sencan O, Akmansu M, Atik ET, Ozbek S. Anticancer Drugs; 2007 Sep; 18(8):969-72. PubMed ID: 17667604 [Abstract] [Full Text] [Related]
3. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C. Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320 [Abstract] [Full Text] [Related]
4. CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate. Chacón M, Roca E, Huertas E, Loria FS, Domenechini E. J Clin Oncol; 2005 Mar 01; 23(7):1580-2. PubMed ID: 15735135 [No Abstract] [Full Text] [Related]
5. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection. Zhu J, Wang Y, Hou M, Li HY, Zhang J. Oncology; 2007 Mar 01; 73(5-6):324-7. PubMed ID: 18497504 [Abstract] [Full Text] [Related]
8. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases]. Garrido S M, Moneada M M, Tapia N G, Méndez O G, Galindo A H, Huete G A, Ibáñez A L, González S, Alvarez Z M. Rev Med Chil; 2007 Oct 01; 135(10):1327-32. PubMed ID: 18180842 [Abstract] [Full Text] [Related]
9. [Treatment of gastrointestinal stromal tumors with imatinib mesylate: a center-based study of 13 patients]. Bar-Sela G, Lev LM, Kuten A, Wollner M, Haim N. Harefuah; 2006 Jan 01; 145(1):2-7, 80. PubMed ID: 16450715 [Abstract] [Full Text] [Related]
11. [A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib]. Sakakura C, Miyagawa K, Fukuda K, Kin S, Nakase Y, Kuriu Y, Nakashima S, Yoshikawa T, Yamaoka N, Sagara Y, Hagiwara A, Yamagishi H. Gan To Kagaku Ryoho; 2005 Oct 01; 32(11):1739-41. PubMed ID: 16315926 [Abstract] [Full Text] [Related]
13. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors]. Wan DS, Wu XJ, Pan ZZ, Zhou ZW, Chen G, Li LR, Lu ZH, Ding PR. Zhonghua Yi Xue Za Zhi; 2006 Nov 21; 86(43):3064-7. PubMed ID: 17288838 [Abstract] [Full Text] [Related]
18. [Long-term survival after surgery and adjuvant imatinib in a patient with rectal GIST, local recurrence, liver metastases and mediastinal pleural metastasis]. Tsutsui M, Yoshino S, Sakamoto K, Oka M. Gan To Kagaku Ryoho; 2009 Nov 21; 36(12):2351-3. PubMed ID: 20037419 [Abstract] [Full Text] [Related]